Clozel looks to next chapter as Idorsia chair

After nearly 27 years at the helm of leading European biotech Actelion and its successor Idorsia, Jean-Paul Clozel is retiring as CEO and will stand for election as chairman of the Swiss biotech. Longtime CFO André Muller will take over the top executive spot on June 13.

Mathieu Simon, the current chair, will stand for re-election to the board, with an eye toward taking on the role of vice-chairman and lead independent director...